Cargando…

Waning immune responses against SARS-CoV-2 variants of concern among vaccinees in Hong Kong

BACKGROUND: Nearly 4 billion doses of the BNT162b2-mRNA and CoronaVac-inactivated vaccines have been administrated globally, yet different vaccine-induced immunity against SARS-CoV-2 variants of concern (VOCs) remain incompletely investigated. METHODS: We compare the immunogenicity and durability of...

Descripción completa

Detalles Bibliográficos
Autores principales: Peng, Qiaoli, Zhou, Runhong, Wang, Yuewen, Zhao, Meiqing, Liu, Na, Li, Shuang, Huang, Haode, Yang, Dawei, Au, Ka-Kit, Wang, Hui, Man, Kwan, Yuen, Kwok-Yung, Chen, Zhiwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8893246/
https://www.ncbi.nlm.nih.gov/pubmed/35248996
http://dx.doi.org/10.1016/j.ebiom.2022.103904
_version_ 1784662350147616768
author Peng, Qiaoli
Zhou, Runhong
Wang, Yuewen
Zhao, Meiqing
Liu, Na
Li, Shuang
Huang, Haode
Yang, Dawei
Au, Ka-Kit
Wang, Hui
Man, Kwan
Yuen, Kwok-Yung
Chen, Zhiwei
author_facet Peng, Qiaoli
Zhou, Runhong
Wang, Yuewen
Zhao, Meiqing
Liu, Na
Li, Shuang
Huang, Haode
Yang, Dawei
Au, Ka-Kit
Wang, Hui
Man, Kwan
Yuen, Kwok-Yung
Chen, Zhiwei
author_sort Peng, Qiaoli
collection PubMed
description BACKGROUND: Nearly 4 billion doses of the BNT162b2-mRNA and CoronaVac-inactivated vaccines have been administrated globally, yet different vaccine-induced immunity against SARS-CoV-2 variants of concern (VOCs) remain incompletely investigated. METHODS: We compare the immunogenicity and durability of these two vaccines among fully vaccinated Hong Kong people. FINDINGS: Standard BNT162b2 and CoronaVac vaccinations were tolerated and induced neutralizing antibody (NAb) (100% and 85.7%) and spike-specific CD4 T cell responses (96.7% and 82.1%), respectively. The geometric mean NAb IC(50) and median frequencies of reactive CD4 subsets were consistently lower among CoronaVac-vaccinees than BNT162b2-vaccinees. CoronaVac did not induce measurable levels of nucleocapsid protein-specific IFN-γ(+) CD4(+) T or IFN-γ(+) CD8(+) T cells compared with unvaccinated. Against VOCs, NAb response rates and geometric mean IC(50) titers against B.1.617.2 (Delta) and B.1.1.529 (Omicron) were significantly lower for CoronaVac (50%, 23.2 and 7.1%, <20) than BNT162b2 (94.1%, 131 and 58.8%, 35.0), respectively. Three months after vaccinations, NAbs to VOCs dropped near to detection limit, along with waning memory T cell responses, mainly among CoronaVac-vaccinees. INTERPRETATION: Our results indicate that vaccinees especially CoronaVac-vaccinees with significantly reduced NAbs may probably face higher risk to pandemic VOCs breakthrough infection. FUNDING: This study was supported by the Hong Kong Research Grants Council Collaborative Research Fund (C7156-20GF and C1134-20GF); the Wellcome Trust (P86433); the National Program on Key Research Project of China (Grant 2020YFC0860600, 2020YFA0707500 and 2020YFA0707504); Shenzhen Science and Technology Program (JSGG20200225151410198 and JCYJ20210324131610027); HKU Development Fund and LKS Faculty of Medicine Matching Fund to AIDS Institute; Hong Kong Innovation and Technology Fund, Innovation and Technology Commission and generous donation from the Friends of Hope Education Fund. Z.C.’s team was also partly supported by the Theme-Based Research Scheme (T11-706/18-N).
format Online
Article
Text
id pubmed-8893246
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-88932462022-03-04 Waning immune responses against SARS-CoV-2 variants of concern among vaccinees in Hong Kong Peng, Qiaoli Zhou, Runhong Wang, Yuewen Zhao, Meiqing Liu, Na Li, Shuang Huang, Haode Yang, Dawei Au, Ka-Kit Wang, Hui Man, Kwan Yuen, Kwok-Yung Chen, Zhiwei EBioMedicine Articles BACKGROUND: Nearly 4 billion doses of the BNT162b2-mRNA and CoronaVac-inactivated vaccines have been administrated globally, yet different vaccine-induced immunity against SARS-CoV-2 variants of concern (VOCs) remain incompletely investigated. METHODS: We compare the immunogenicity and durability of these two vaccines among fully vaccinated Hong Kong people. FINDINGS: Standard BNT162b2 and CoronaVac vaccinations were tolerated and induced neutralizing antibody (NAb) (100% and 85.7%) and spike-specific CD4 T cell responses (96.7% and 82.1%), respectively. The geometric mean NAb IC(50) and median frequencies of reactive CD4 subsets were consistently lower among CoronaVac-vaccinees than BNT162b2-vaccinees. CoronaVac did not induce measurable levels of nucleocapsid protein-specific IFN-γ(+) CD4(+) T or IFN-γ(+) CD8(+) T cells compared with unvaccinated. Against VOCs, NAb response rates and geometric mean IC(50) titers against B.1.617.2 (Delta) and B.1.1.529 (Omicron) were significantly lower for CoronaVac (50%, 23.2 and 7.1%, <20) than BNT162b2 (94.1%, 131 and 58.8%, 35.0), respectively. Three months after vaccinations, NAbs to VOCs dropped near to detection limit, along with waning memory T cell responses, mainly among CoronaVac-vaccinees. INTERPRETATION: Our results indicate that vaccinees especially CoronaVac-vaccinees with significantly reduced NAbs may probably face higher risk to pandemic VOCs breakthrough infection. FUNDING: This study was supported by the Hong Kong Research Grants Council Collaborative Research Fund (C7156-20GF and C1134-20GF); the Wellcome Trust (P86433); the National Program on Key Research Project of China (Grant 2020YFC0860600, 2020YFA0707500 and 2020YFA0707504); Shenzhen Science and Technology Program (JSGG20200225151410198 and JCYJ20210324131610027); HKU Development Fund and LKS Faculty of Medicine Matching Fund to AIDS Institute; Hong Kong Innovation and Technology Fund, Innovation and Technology Commission and generous donation from the Friends of Hope Education Fund. Z.C.’s team was also partly supported by the Theme-Based Research Scheme (T11-706/18-N). Elsevier 2022-03-03 /pmc/articles/PMC8893246/ /pubmed/35248996 http://dx.doi.org/10.1016/j.ebiom.2022.103904 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Articles
Peng, Qiaoli
Zhou, Runhong
Wang, Yuewen
Zhao, Meiqing
Liu, Na
Li, Shuang
Huang, Haode
Yang, Dawei
Au, Ka-Kit
Wang, Hui
Man, Kwan
Yuen, Kwok-Yung
Chen, Zhiwei
Waning immune responses against SARS-CoV-2 variants of concern among vaccinees in Hong Kong
title Waning immune responses against SARS-CoV-2 variants of concern among vaccinees in Hong Kong
title_full Waning immune responses against SARS-CoV-2 variants of concern among vaccinees in Hong Kong
title_fullStr Waning immune responses against SARS-CoV-2 variants of concern among vaccinees in Hong Kong
title_full_unstemmed Waning immune responses against SARS-CoV-2 variants of concern among vaccinees in Hong Kong
title_short Waning immune responses against SARS-CoV-2 variants of concern among vaccinees in Hong Kong
title_sort waning immune responses against sars-cov-2 variants of concern among vaccinees in hong kong
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8893246/
https://www.ncbi.nlm.nih.gov/pubmed/35248996
http://dx.doi.org/10.1016/j.ebiom.2022.103904
work_keys_str_mv AT pengqiaoli waningimmuneresponsesagainstsarscov2variantsofconcernamongvaccineesinhongkong
AT zhourunhong waningimmuneresponsesagainstsarscov2variantsofconcernamongvaccineesinhongkong
AT wangyuewen waningimmuneresponsesagainstsarscov2variantsofconcernamongvaccineesinhongkong
AT zhaomeiqing waningimmuneresponsesagainstsarscov2variantsofconcernamongvaccineesinhongkong
AT liuna waningimmuneresponsesagainstsarscov2variantsofconcernamongvaccineesinhongkong
AT lishuang waningimmuneresponsesagainstsarscov2variantsofconcernamongvaccineesinhongkong
AT huanghaode waningimmuneresponsesagainstsarscov2variantsofconcernamongvaccineesinhongkong
AT yangdawei waningimmuneresponsesagainstsarscov2variantsofconcernamongvaccineesinhongkong
AT aukakit waningimmuneresponsesagainstsarscov2variantsofconcernamongvaccineesinhongkong
AT wanghui waningimmuneresponsesagainstsarscov2variantsofconcernamongvaccineesinhongkong
AT mankwan waningimmuneresponsesagainstsarscov2variantsofconcernamongvaccineesinhongkong
AT yuenkwokyung waningimmuneresponsesagainstsarscov2variantsofconcernamongvaccineesinhongkong
AT chenzhiwei waningimmuneresponsesagainstsarscov2variantsofconcernamongvaccineesinhongkong